Sumitomo Mitsui Trust Holdings, Inc. Recursion Pharmaceuticals, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $138 Billion
- Q1 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 8,479,284 shares of RXRX stock, worth $40.4 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
8,479,284
Previous 8,980,601
5.58%
Holding current value
$40.4 Million
Previous $60.7 Million
26.11%
% of portfolio
0.03%
Previous 0.04%
Shares
16 transactions
Others Institutions Holding RXRX
# of Institutions
355Shares Held
287MCall Options Held
2.83MPut Options Held
3.64M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$166 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$154 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$116 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$82.4 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$69.8 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $859M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...